CLINICAL CHARACTERISTICS OF MEASLES IN ADULTS
DOI:
https://doi.org/10.34921/amj.2024.1.009Keywords:
measles, Koplik spots, hepatomegaly, vaccinationAbstract
The article provides information about the results of a scientific study conducted to study the epidemiological and clinical characteristics of measles in adults. Materials of 28 adult patients between 18-45 years of age with measles were included in the study. The analysis of the age structure of measles patients among adults showed that the majority of patients - 71.4% were between 18-30 years old. 21.4% of patients aged 31-41, and 42 and older accounted for only 7.1%. The disease was moderately severe in 85.7% (23) cases, and severe in 14.3% (5) patients. Among the patients, there were more people who had not been vaccinated against measles and those whose vaccination status was unknown, which comprised 78.6% of the patients. The presence of unvaccinated people, high population migration and touristic activity have created conditions for the increase and spread of both local and imported cases of the disease. In 21.4% of patients, the pathognomonic symptom - the absence of Koplik's spots, in 85.7% of patients, the increase of transaminases, and in 42.9% - hepatomegaly, in the early stage of the disease - in the period of catarrhal symptoms, the development of diarrhea syndrome was observed in 25% of cases. Currently, atypical forms of the disease are more common, which makes it difficult to make a diagnosis at the time of the disease - before the hospital. So, at this stage, the diagnosis of "measles" was determined only in 25% of patients. The mentioned factors are considered to be the factors contributing to the unjustified prescribing of antibacterial agents and failure to take anti-epidemic measures on time.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Azerbaijan Medical Journal
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.